Case Study # 1: From Low Adoption to 43% Growth

When a leading pharmaceutical company faced an unexpected challenge after launching a new treatment, they turned to Biotech & Pharma Consulting for answers—and results.
The Challenge
Despite a successful product launch, physician adoption was significantly below expectations.
“Physicians aren’t prescribing our new treatment as expected. We need help identifying why—and turning it around.” – Marketing Lead, Pharma Client

Our Diagnosis
After working closely with their Marketing, Sales, Medical Affairs, and Market Research teams, we quickly identified two major barriers:

• Lack of clear differentiation versus competitors
• Minimal endorsement from respected Opinion Leaders (OLs)

Our Solution
We designed a two-pronged strategy that would not only address the core issues but also deliver tangible commercial results:
Tailored Digital Communication Campaign
→ Custom messages targeted to segmented HCP audiences
→ Clear articulation of product benefits vs. competition
→ Enhanced engagement across digital touchpoints
KOL Activation & Peer Influence
→ Developed an Ambassador Excellence Program: a closed-door session where OLs aligned around key brand messages
→ Followed by an Expert Summit where those OLs educated high-prescribing peers on the product's value proposition

The Results
Message Clarity Improved – Key differentiation messages increased brand clarity by 37%. Physicians gained a stronger understanding of the product’s unique value within 12 months.
Stronger Brand Advocacy – KOL alignment reinforced consistent brand messaging and amplified peer-to-peer influence across key markets.
Significant Market Growth – Prescription volume and market share rose by 43% year-over-year in the second year post-launch.